A process for the preparation of a penam derivative of formula (I): IMAGE (I) wherein RA is hydrogen or a group of formula (Ia): IMAGE (Ia) wherein X is -CO2R1, or SO3R1; R is C1-6alkyl, aryl, or heterocyclyl; R1 is hydrogen, or a pharmaceutically acceptable salt-forming ion or ester-forming radical, and R2 represents hydrogen or a pharmaceutically acceptable salt-forming ion or in vivo hydrolyzable ester-forming radical; which process comprises reacting a compound of formula (II): IMAGE (II) wherein RB is hydrogen, a removable amino blocking group, or a group of formula (IIa): IMAGE (IIa) wherein Y is -CO2Rx or -SO3Rx; R is as defined with respect to formula (I) above; Rx represents an ester-forming radical, RY represents hydrogen, a salt-forming radical or a carboxyl-blocking group, and R3 represents an alkyl, benzyl, or aryl group; with methanol in the presence of copper ions; and thereafter if necessary carrying out one or more of the following steps: (i) removal of any blocking group; (ii) converting the product to a pharmaceutically acceptable salt or ester thereof.
展开▼
机译:制备式(I):(IM)>(I)的戊烯衍生物的方法,其中RA是氢或式(Ia)的基团:(Ia),其中X是-CO2R1,或SO3R1; R为C 1-6烷基,芳基或杂环基; R 1为氢或药学上可接受的成盐离子或成酯基,R 2为氢或药学上可接受的成盐离子或体内可水解成酯基;该方法包括使其中RB为氢的式(II)化合物:(II),可移动的氨基保护基或其中Y为-CO2Rx的式(IIa)基团:(IIa)或-SO 3 R x; R如上式(I)所定义; Rx代表成酯基,RY代表氢,成盐基或羧基保护基,R3代表烷基,苄基或芳基。在铜离子存在下与甲醇反应;然后在必要时进行以下一个或多个步骤:(i)除去任何保护基团; (ii)将产物转化为其药学上可接受的盐或酯。
展开▼